Ashwin Kishtagari
LightNews LightNews
ashkishtaagri.bsky.social
Ashwin Kishtagari
@ashkishtaagri.bsky.social
3 followers 65 following 8 posts
Posts Replies Media Videos
Reposted by Ashwin Kishtagari
cancertherapyadv.bsky.social
The recent EHA 2025 Congress showcased novel combinations for MDS and AML as well as a novel formulation of a drug for B-ALL: an opinion piece by @ashkishtaagri.bsky.social of @vanderbilt.edu shorturl.at/RkY2M #EHA2025 #leusm #mdssm
Opinion: Top Studies From EHA 2025
Ashwin Kishtagari, MD, of Vanderbilt University Medical Center in Nashville, summarizes 7 studies presented at the EHA 2025 Congress.
shorturl.at
July 7, 2025 at 4:07 PM
Reposted by Ashwin Kishtagari
cancertherapyadv.bsky.social
Dr Ashwin Kishtagari (@ashkishtaagri.bsky.social) of @vumedicine.bsky.social shares his top picks from #SOHO2025. #SOHO25 Read about them here:
www.cancertherapyadvisor.com/features/soh...
Dr Ashwin Kishtagari’s Top 4 Picks From SOHO 2025
Ashwin Kishtagari, MD, shares his top 4 picks from the abstracts presented at the 13th annual meeting of the Society of Hematologic Oncology.
www.cancertherapyadvisor.com
October 3, 2025 at 3:45 PM
ashkishtaagri.bsky.social
I am thrilled to share our new publication in @eclinicalmed.bsky.social co-led with a superb VUMC IM resident James Brogan: "Incident cytopenia and risk of subsequent myeloid neoplasm in age-related clonal hematopoiesis"
Incident cytopenia and risk of subsequent myeloid neoplasm in age-related clonal hematopoiesis: a multi-biobank case-control study
Cross sectional studies have demonstrated patients with clonal hematopoiesis of indeterminate potential (CHIP) are at increased risk of developing mul…
https://sciencedirect.com/science/article/pii/S2589537025002159…
June 5, 2025 at 12:52 AM